Related Experiment Video
Updated: Jul 11, 2026

Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice
Published on: March 15, 2024
Pharmacogenomics of mental illnesses: do sex-specific differences matter?
1Department of Biology and Medical Genetics, School of Medicine, University of Rijeka, Braće Branchetta 20, 51 000 Rijeka, Croatia. alena@medri.hr
Objectives:
Genetic factors are extensively studied in respect to drug response in psychiatric disorders. Recent evidence suggests that action of reproductive steroid hormones in brain may also have a role.
Methods:
Sex-specific differences in terms of illness onset, duration, severity of symptoms and treatment response are well documented. It is believed they result from different brain morphology and function between sexes, factors being highly influenced by sex hormones.
Results:
The synergistic effects of the genetic background and potential prenatal stressors may influence the processes of sexual brain maturation, the most vulnerable period for developing susceptibility for psychiatric disorders. A resulting neuroendocrine dysfunction implies inadequate response of brain structures to pubertal flow of circulating sex hormones.
Conclusion:
Steroid sex hormones, at least estrogen, are major parts of the communication system in the brain. For that reason, estrogen receptors could be attractive targets in development of new treatment strategies. Potential benefits from compounds mimicking estrogen should be also considered in clinical practice.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics and Pharmacogenomics: Overview
Principles of Pharmacogenetics: Types of Genetic Variants
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenomics: Identification of New Drug Targets

